New York, NY, March 6, 2013—Health economists funded by the American Diabetes Association released an update today of their analysis of the costs of diabetes in the United States, noting an increase in cost of 41 percent, from $174 billion in 2007 to $245 billion in 2012. The analysis points to the rise in diabetes as a catalyst for this alarming increase. Both type 1 and type 2 diabetes are rising.
“As the leading global organization focused on type 1 diabetes (T1D) research, JDRF knows the heavy toll that diabetes places on our nation’s economy, and on all those living with the disease,” said Cynthia Rice, JDRF vice president of government relations. “We will not rest until the burdens of T1D have been lifted, and will continue to fund over $100 million in T1D research and advocate tirelessly for federal support of research including renewal of the Special Diabetes Program. “
In 2012, JDRF released a study showing that therapies to improve glucose control could save the Medicare program $190 billion over the course of 25 years. Research to cure, treat, and prevent diabetes is not only needed for those living with T1D; it is also pertinent to the long-term fiscal health of our country. A detailed account of JDRF’s study, which shows the potential Medicare savings from research advances, can be found here.